What is the appropriate treatment for a chronic vertebral compression fracture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Chronic Vertebral Compression Fractures

For chronic osteoporotic vertebral compression fractures, conservative management with pain control and osteoporosis treatment should be the initial approach, with vertebral augmentation (kyphoplasty preferred over vertebroplasty) reserved for patients with persistent pain after 3 months of failed conservative therapy.

Initial Conservative Management

The foundation of treatment for chronic compression fractures centers on:

  • Pain management: While evidence for specific analgesics is limited 1, NSAIDs and acetaminophen are reasonable first-line options. Opioids may be necessary but carry risks of prolonged use 2
  • Osteoporosis pharmacotherapy: Ibandronate and strontium ranelate are specifically recommended to prevent additional symptomatic fractures 1
  • Early mobilization: Avoid prolonged bed rest, which increases deconditioning and fall risk 2

Important Caveats on Conservative Measures

The evidence base has significant gaps. No recommendation can be made for or against bed rest, bracing, or exercise programs due to inconclusive evidence 1. While one study suggested bracing might help, it was downgraded to inconclusive because fracture age and level weren't reported, and only one brace type was studied 1. Similarly, exercise programs showed mixed results across different quality-of-life domains at various time points 1.

When Conservative Treatment Fails

Timing for Vertebral Augmentation

Consider vertebral augmentation after 3 months of failed conservative therapy 2. Failure is defined as:

  • Pain refractory to oral medications (NSAIDs or narcotics)
  • Contraindication to oral medications
  • Requirement for parenteral narcotics or hospital admission

The more recent ACR guideline (2018) notes that the threshold for performing vertebral augmentation has declined given evidence of superior pain relief compared to prolonged medical treatment 2.

Critical Evidence on Vertebroplasty vs. Kyphoplasty

The 2011 AAOS guideline strongly recommends AGAINST vertebroplasty based on two Level I sham-controlled trials showing no statistically significant or clinically important difference in pain or function 1. This represents high-quality evidence that vertebroplasty provides no benefit beyond placebo.

However, the more recent 2018 ACR guideline takes a different stance, noting that multiple studies demonstrated benefit of vertebral augmentation versus conservative treatment, with a multisociety position statement concluding vertebral augmentation is "clearly beneficial in the short term and likely beneficial also in the long term" 2. This divergence reflects ongoing controversy in the field.

For kyphoplasty specifically, the evidence is more favorable. Research shows:

  • Pain relief occurs in 87% of chronic fractures 3
  • Height restoration averages from 56% to 79% of estimated normal vertebral height in chronic fractures 3
  • Chronic fractures (>4 months old) still achieve meaningful pain relief and some kyphosis correction, though less height restoration than acute fractures 3

Practical Algorithm for Chronic Fractures

  1. First 3 months: Conservative management with analgesics, osteoporosis treatment, and mobilization
  2. After 3 months of persistent pain: Consider vertebral augmentation
    • Kyphoplasty is preferred over vertebroplasty given the strong evidence against vertebroplasty 1 and favorable outcomes with kyphoplasty in chronic fractures 3
    • Even fractures >1 year old may benefit from pain relief, though height restoration is less predictable 4, 5

Surgical Indications

Refer for surgical consultation if any of the following are present 2:

  • Neurologic deficits
  • Spinal deformity (junctional kyphosis, retropulsion)
  • Spinal instability

These represent absolute indications for open surgical intervention rather than percutaneous augmentation.

Special Considerations

Chronic vs. Acute Fractures

The distinction matters less than previously thought. Research shows that fractures >12 weeks old have equivalent benefit from vertebroplasty compared to those <12 weeks, suggesting fracture age doesn't independently affect outcomes 2. However, acute fractures do achieve better height restoration with kyphoplasty (60% vs. 26% achieving ≥89% normal height) 3.

Biopsy Consideration

Biopsy can be performed during vertebral augmentation to verify etiology and has detected unsuspected malignancy 2. This is particularly important in chronic fractures where the pain source may be questioned.

Common Pitfall

Do not assume all back pain in patients with chronic compression fractures is fracture-related. The evidence is weak on whether radiographic fractures, especially chronic ones, are truly the source of symptoms 1. This underscores the importance of correlating imaging findings with clinical examination and considering alternative pain sources before proceeding with augmentation.

Related Questions

What is the appropriate treatment for a vertebral compression fracture?
What is the recommended treatment for a lumbar vertebral compression fracture at L1 with retropulsion of bone fragments into the central canal?
What are the appropriate next steps in management for an 85-year-old male with a new L1 vertebral compression fracture identified on CT?
In a 72‑year‑old woman presenting with chronic upper‑thoracic back pain that worsens with movement and deep breathing, height loss of approximately 2 inches, and kyphotic posture, what are the salient clinical features, pertinent risk factors, involved anatomy, recommended physical‑exam maneuvers, appropriate diagnostic studies, the anatomic basis of her signs and symptoms, the most likely diagnosis, and potential complications if left untreated?
What is the recommended medical management for an 85-year-old male with an L1 vertebral compression fracture, rib fractures, and a hip T-score of –2 on dual-energy X-ray absorptiometry?
What is the recommended dose of eperisone and Phos‑NaK to be administered three times daily for a single 24‑hour period?
What is the recommended treatment for major depressive disorder in adults with autism spectrum disorder?
How should eperisone be taken daily and Phosnak (phosphate binder) be taken three times daily for a single day?
Is it safe to co-administer eplerenone with Phos‑NaK (potassium‑containing phosphate preparation)?
Can you interpret the imaging studies for a 67‑year‑old female with left shoulder pain and intermittent popping, worsened by turning while driving, with no recent trauma, weakness, radiation, or prior injury?
What are the possible causes and clinical significance of a hypodense area on a CT scan in an adult patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.